VANGUARD GROUP INC - LION BIOTECHNOLOGIES INC ownership

LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 83 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$16,726,000
+8.4%
2,245,199
+1.2%
0.00%0.0%
Q4 2016$15,423,000
-12.6%
2,219,160
+3.4%
0.00%0.0%
Q3 2016$17,656,000
+34.4%
2,145,359
+32.3%
0.00%0.0%
Q2 2016$13,136,000
+59.1%
1,621,810
-0.3%
0.00%0.0%
Q1 2016$8,259,000
-29.2%
1,625,946
+7.6%
0.00%0.0%
Q4 2015$11,661,000
+41.5%
1,510,556
+5.6%
0.00%
Q3 2015$8,242,000
-29.2%
1,430,956
+12.7%
0.00%
-100.0%
Q2 2015$11,639,000
+251.1%
1,269,233
+363.6%
0.00%
Q1 2015$3,315,000273,7560.00%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q3 2015
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,232,416$26,183,00012.58%
Avoro Capital Advisors LLC 4,338,557$35,142,0007.81%
FRAZIER MANAGEMENT LLC 774,720$6,275,0005.00%
Broadfin Capital, LLC 3,170,759$25,683,0002.50%
Perceptive Advisors 3,611,976$29,257,0002.03%
Ghost Tree Capital, LLC 700,000$5,670,0001.64%
Opaleye Management Inc. 260,000$2,106,0001.41%
Rhenman & Partners Asset Management AB 650,000$5,265,0000.94%
QVT Financial LP 1,598,309$12,946,0000.89%
Cormorant Asset Management, LP 505,941$4,098,0000.58%
View complete list of LION BIOTECHNOLOGIES INC shareholders